Tower Research Capital (TRC)’s Imago BioSciences, Inc. Common stock IMGO Stock Holding History

Tower Research Capital (TRC)’s Portfolio IMGO Stock Details IMGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-3,493	Closed	-$125K	–	6756
2022 Q4	$125K	Sell	3,493 -2,150	-38%	-$53.8K	0.01%	1659
2022 Q3	$85K	Buy	5,643 +4,250	+305%	+$68.9K	﹤0.01%	2706
2022 Q2	$19K	Buy	1,393 +863	+163%	+$13.7K	﹤0.01%	3875
2022 Q1	$10K	Sell	530 -650	-55%	-$13.5K	﹤0.01%	4407
2021 Q4	$28K	Buy	1,180 +747	+173%	+$17.3K	﹤0.01%	3326
2021 Q3	$9K	Buy	+433	New	+$9.29K	﹤0.01%	4494

Tower Research Capital (TRC)'s IMGO Position: Q1 2023 in Review

Tower Research Capital (TRC) sold out of Imago BioSciences, Inc. Common stock (IMGO) in Q1 2023, closing a stake of 3,493 shares — an estimated $125K sold.

Tower Research Capital (TRC) first reported a position in IMGO in Q3 2021 and held it in 6 quarters. The position peaked at $125K in Q4 2022. 0 funds tracked by Wall St. Rank hold IMGO as of Q1 2023.

Tower Research Capital (TRC) reported no remaining Imago BioSciences, Inc. Common stock position as of Q1 2023 after selling out during the quarter.
Tower Research Capital (TRC) sold 3,493 Imago BioSciences, Inc. Common stock shares in Q1 2023, an estimated $125K.
Tower Research Capital (TRC) first reported a position in Imago BioSciences, Inc. Common stock in Q3 2021 and held it in 6 quarters.
Tower Research Capital (TRC)'s Imago BioSciences, Inc. Common stock position peaked at $125K in Q4 2022.
0 funds tracked by Wall St. Rank held Imago BioSciences, Inc. Common stock as of Q1 2023.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2023, filed 9 May 2023.